Should We Always Defer Treatment of Kidney Disease When There Is Extensive Interstitial Fibrosis on Biopsy?

Publisher： Karger

E-ISSN： 1421-9670|44|4|286-288

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.44, Iss.4, 2016-09, pp. : 286-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts

By  

American Journal of Nephrology, Vol. 44, Iss. 4, 2016-09 ,pp. : 289-299

Karger

Access to resources Recommend Favorite

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

By  

Nephron, Vol. 133, Iss. 3, 2016-06 ,pp. : 147-158

Karger

Access to resources Recommend Favorite

When Should Renal Replacement Therapy for Acute Kidney Injury Be Initiated and Discontinued?

By  

Blood Purification, Vol. 26, Iss. 5, 2008-09 ,pp. : 473-484

Karger

Access to resources Recommend Favorite

When Should Renal Replacement Therapy for Acute Kidney Injury Be Initiated and Discontinued?

By  

Blood Purification, Vol. 27, Iss. 3, 2009-02 ,pp. : 247-247

Karger

Access to resources Recommend Favorite

Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 300-306

Karger

Access to resources Recommend Favorite